VANCOUVER, July 3 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. (TSX: DDD; OTCBB: DRUG; BBSE: DRP) today announced the sale of 3,496,503 shares of restricted common stock to a vendor at an offering price of $0.429 per share, with a total of US$1.5 million. The transaction was completed on July 1, 2007. These shares were sold in a private transaction and therefore, subject to restriction for free trading. CONTACT: Dragon Pharmaceutical Inc., Maggie Deng, COO, Telephone: (604) 669-8817 or North America Toll Free: 1-877-388-3784, Email: , Website: http://www.dragonpharma.com/ DATASOURCE: Dragon Pharmaceutical Inc. CONTACT: Dragon Pharmaceutical Inc., Maggie Deng, COO, Telephone: (604) 669-8817 or North America Toll Free: 1-877-388-3784, Email: , Website: http://www.dragonpharma.com/

Copyright